National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 5/14/2021 release of VAERS data (an older release, current is 7/16/2021):

This is VAERS ID 1255323

Case Details

VAERS ID: 1255323 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: Virginia  
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Private       Purchased by: ?
Symptoms: Fall, Headache, Hyperhidrosis, Nausea, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: LEXAPRO
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Fatty liver; Sulfonamide allergy
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021396111

Write-up: went to go lay back down/fainted; went to go lay back down; felt nauseous; Went to lay in bed and was sweating a lot; Before I fainted I had taken some ibuprofen for the headache; This is a spontaneous report from a contactable consumer patient(herself) reported. A 35-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EM9810, Expiration date: unknown), via an unspecified route of administration in arm left on 10Apr2021 at 12:00 PM as single dose for covid-19 immunization. The patient historical vaccine included first dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EM9810, Expiration date: unknown), via an unspecified route of administration in left arm on 20Mar2021 at12:00 PM as single dose Covid-19 immunization. Patient medical history included fatty liver disease. Patient had known to allergies sulfa medication. Patient concomitant medication in two weeks included escitalopram oxalate (LEXAPRO), allergy medicine, allergy nasal spray. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the post vaccination. Patient experienced about 16 hours after the vaccine went to go lay back down, felt nauseous and fainted, got back up and fainted again. Went to lay in bed and was sweating a lot 11Apr2021 at 05:15 AM. Before fainted, patient had taken some ibuprofen for the headache. Patient not received treatment for the events. The outcome of the event was unknown.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166